Dabur recalls

The FDA identified manufacturing deficiencies during inspection of Med Pride Triple Antibiotic Ointment (1oz tubes). Multiple lots do not meet required manufacturing standards. No injuries have been reported.

Med Pride Triple Antibiotic Ointment packets were found to have manufacturing quality deficiencies during an FDA inspection. The affected lots do not meet federal quality standards, though no injuries have been reported.

The FDA found manufacturing deficiencies during an inspection of the facility that produces Med Pride Hydrocortisone Cream 1%. These deviations from proper manufacturing standards affected multiple lots of the product currently still within their expiration dates.

The FDA found manufacturing quality control problems (CGMP deviations) during an inspection of the facility that makes Med Pride Hydrocortisone Cream 1%. Multiple lots of the product are affected. No injuries have been reported.

The FDA found manufacturing deficiencies during an inspection of Med Pride 1% Clotrimazole Antifungal Cream. These deficiencies do not meet federal good manufacturing practice standards. About 5,755 tubes across multiple lots are affected.

The FDA found manufacturing deficiencies during an inspection of the facility that made Med Pride Bacitracin Zinc Ointment. This affects specific batches (Lot #022, 023, and 024) distributed nationwide.

The FDA found manufacturing quality control problems during an inspection of the facility that produced Med Pride Bacitracin Zinc Ointment. This ointment is used to help prevent infection in minor cuts and scrapes. The affected batches were distributed nationwide.

The FDA identified manufacturing quality control problems during an inspection of the facility that produces Med Pride Bacitracin Zinc Ointment. Certain lot numbers do not meet federal manufacturing standards for sterile wound-care products.

Dabur India Limited's Cura Hongos antifungal cream (clotrimazole 1%, 2oz tubes) was found to have manufacturing deficiencies during an FDA inspection. The affected product (Lot #0003) does not meet U.S. manufacturing standards. No injuries have been reported.

The FDA found manufacturing deficiencies during an inspection of the facility that made Rapidol Triple Antibiotic First Aid Ointment. The product does not meet federal manufacturing standards. About 84 tubes (Lot 0004) were distributed nationwide.

The FDA identified manufacturing deficiencies during an inspection of this triple antibiotic ointment product. The affected lot (0005) is still within its expiration date. No injuries have been reported.

Circle K triple antibiotic ointment tubes manufactured by Dabur India Limited have been recalled due to deficiencies found during an FDA inspection. The affected lots (0001 and 0005) do not meet current manufacturing standards for sterile products.

The FDA inspected the manufacturer of Lucky Super Soft First Aid Triple Antibiotic Ointment and found deficiencies in how the product was made and quality-controlled. The affected tubes are lot numbers 0002 and 0003, which are still within their expiration dates.

Dabur India Limited's Lucky Super Soft Antifungal Athlete's Foot Cream (Clotrimazole 1%, 1.5 oz tubes) is being recalled due to manufacturing deficiencies found during an FDA inspection. The affected lots (0001 and 0002) were distributed nationwide.